Glaukos (GKOS) Interest & Investment Income (2014 - 2026)
Glaukos (GKOS) posted quarterly Interest & Investment Income of $2.3 million for Q2 2026, down 11.46% year-over-year from $2.6 million in Q2 2025, and down 6.25% quarter-over-quarter from $2.4 million in Q1 2026.
Glaukos (GKOS) Interest & Investment Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Interest & Investment Income for 13 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest & Investment Income fell 11.46% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $9.8 million (down 9.87% YoY), while the FY2025 annual figure was $10.7 million, down 3.52% from the prior year.
- Interest & Investment Income fell to $2.3 million in Q2 2026 per GKOS's latest filing, from $2.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $12.2 million in Q4 2022 and bottomed at -$5.9 million in Q2 2022.
- Historically, Interest & Investment Income has averaged $2.1 million across 5 years, with a median of $2.5 million in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income sank 1810.82% — and 2023, when it surged 271.67%.
- Glaukos' Interest & Investment Income stood at $12.2 million in 2022, then tumbled by 76.07% to $2.9 million in 2023, then fell by 14.35% to $2.5 million in 2024, then climbed by 0.72% to $2.5 million in 2025, then dropped by 9.28% to $2.3 million in 2026.
- Business Quant data shows GKOS's Interest & Investment Income at $2.3 million in Q2 2026, $2.4 million in Q1 2026, and $2.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Glaukos | 11.19 Bn | 11.08 Bn | 151.59 Mn | 2.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 2.43 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 12.17 Mn |
| Sep 30, 2022 | -2.98 Mn |
| Jun 30, 2022 | -5.85 Mn |
| Mar 31, 2022 | -960,000.00 |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | -1.47 Mn |